|
MSI2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.678270E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.296800E-03 |
| Normal-vs-Stage2 |
6.277600E-02 |
| Normal-vs-Stage3 |
1.412410E-04 |
| Normal-vs-Stage4 |
1.018860E-04 |
| Stage1-vs-Stage2 |
8.697000E-01 |
| Stage1-vs-Stage3 |
1.178630E-01 |
| Stage1-vs-Stage4 |
5.899700E-02 |
| Stage2-vs-Stage3 |
2.368200E-01 |
| Stage2-vs-Stage4 |
1.591850E-01 |
| Stage3-vs-Stage4 |
5.936800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.838100E-04 |
| Normal-vs-AfricanAmerican |
6.810400E-01 |
| Normal-vs-Asian |
3.461800E-03 |
| Caucasian-vs-AfricanAmerican |
7.872300E-02 |
| Caucasian-vs-Asian |
8.043600E-01 |
| AfricanAmerican-vs-Asian |
1.067430E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.79330000030731E-07 |
| Normal-vs-Female |
4.395400E-03 |
| Male-vs-Female |
1.623940E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.007700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.600010E-03 |
| Normal-vs-Age(61-80Yrs) |
1.419710E-04 |
| Normal-vs-Age(81-100Yrs) |
1.757750E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.572800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.450000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.964400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.547800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.313800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.743200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.609000E-04 |
| Classical-VS-Follicular |
2.288400E-02 |
| Classical-VS-Other |
1.559380E-01 |
| Classical-VS-Normal |
2.943700E-02 |
| Tall-VS-Follicular |
2.427000E-01 |
| Tall-VS-Other |
7.735400E-01 |
| Tall-VS-Normal |
1.64110000000495E-06 |
| Follicular-VS-Other |
4.933400E-01 |
| Follicular-VS-Normal |
2.588300E-04 |
| Other-VS-Normal |
1.122490E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.201300E-04 |
| Normal-vs-N1 |
1.556620E-03 |
| N0-vs-N1 |
4.782400E-01 |
|
|
